1. James N. Kochenderfer, MD, on Multiple Myeloma: Results of a First-in-Humans Clinical Trial


    from Harborside Press Added 70 0 0

    James N. Kochenderfer, MD, of the National Cancer Institute, reports on remissions of multiple myeloma during a trial of T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor.…

    + More details
    • Stephen J. Schuster, MD, on CD19+ Lymphomas: Sustained Remissions in Relapsed or Refractory Disease


      from Harborside Press Added 54 0 0

      Stephen J. Schuster, MD, of the University of Pennsylvania, discusses the findings of a study of chimeric antigen receptor modified T cells directed against CD19 in patients with relapsed or refractory…

      + More details
      • Julie Vose, MD, MBA, and Cameron J. Turtle, MBBS, PhD, on B-Cell NHL and CLL: Clinical Trial Results on T-Cell Therapy


        from Harborside Press Added 221 0 0

        Julie Vose, MD, MBA, of the University of Nebraska Medical Center, and Cameron J. Turtle, MBBS, PhD, of the Fred Hutchinson Cancer Research Center, discuss anti-CD19 chimeric antigen receptor-modified…

        + More details
        • ASH 2014: ALL Treatment Advances with Chimeric Antigen Receptor (CAR) Therapy


          from Patient Power Added 110 1 0

          During the 2014 American Society of Hematology (ASH) annual meeting, Dr. Stephen Grupp from the Children’s Hospital of Philadelphia joined Patient Power to discuss CAR therapy for acute lymphoblastic…

          + More details
          • ASH 2014: Acute Lymphoblastic Leukemia (ALL) Update


            from Patient Power Added 104 1 0

            During the 2014 American Society of Hematology (ASH) meeting, Seattle Cancer Care Alliance's Dr. Ryan Cassaday provided updates on the latest research and treatment news for acute lymphoblastic…

            + More details
            • Title Risks Associated with Transplant in CLL


              from Patient Power Added 375 0 0

              CLL expert Dr. Januario Castro, explores the role of transplant in CLL treatment, how it works, and the risks associated with this procedure.

              + More details
              • The Role of Genetic Profiling When Choosing CLL Treatment


                from Patient Power Added 437 0 0

                With so many new treatment options for CLL, how do you choose a treatment that’s right for you? Dr. Januario Castro of UC San Diego Moores Cancer Center explores how genetics play a role when…

                + More details
                • How Do Prognostic Factors Affect CLL Treatment Options?


                  from Patient Power Added 743 0 0

                  MD Anderson expert, Dr. Michael Keating, takes the audience through the process of making treatment choices. He explains the prognostic factors that come into play and the tests he relies upon most…

                  + More details
                  • Why You Should Discuss CLL Clinical Trials with Your Doctor


                    from Patient Power Added 339 0 0

                    CLL expert Dr. Januario Castro explains why clinical trials are vital to progress in CLL treatment as well as the benefit to patients.

                    + More details
                    • Treating CLL: What's New or Coming Soon?


                      from Patient Power Added 163 0 0

                      Dr. Januario Castro, an expert from UC San Diego Moores Cancer Center, reviews recently approved and promising therapies in development to treat CLL. Dr. Castro discusses the importance of clinical…

                      + More details

                      What are Tags?


                      Tags are keywords that describe videos. For example, a video of your Hawaiian vacation might be tagged with "Hawaii," "beach," "surfing," and "sunburn."